Skip to main content

Optimizing Glycosylation Reaction Selectivities by Protecting Group Manipulation

Buy Article:

$68.00 + tax (Refund Policy)

Due to their biological importance, oligosaccharides and glycoconjugates have recently gained much attention. Investigations of such compounds often require chemically synthesized oligosaccharides. In the oligosaccharide synthesis, glycosylation reaction is frequently the most important step. Recently, one-pot multi-step glycosylations have become popular using the glycosyl donors with different reactivities and a polymer-supported technology that can reduce the laborious purification operations. For such methodologies, stereoselective glycosylation is essential.

Compared to the 1,2-trans-glycoside formation, highly cis-selective glycosylation has remained relatively elusive. To enhance cis-selectivity, protection of the 2-position using a benzyl type ether and solvent effects are often employed. Recent reports have described the manipulation of protecting groups to afford novel donors that allow improved cisselective glycosylation. This manuscript reviews such donors that have been reported within the last five years. We hope this manuscript proves to be helpful in furthering the chemical syntheses of oligosaccharides while improving our understanding of the glycosylation reaction including stereoelectronic effects.



Keywords: Glycosylation reaction; protecting group; stereoselectivity

Document Type: Research Article

Publication date: 01 December 2008

More about this publication?
  • The journal aims to provide updates to researchers about new bioactive compounds with proven activities in various biological screenings and pharmacological models. The journal will contain information about the structures, biological activities and sources of chemical entities discovered or designed by researchers and published in leading journals. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia.

    The journal should prove to be essential reading for pharmacologists, pharmaceutical chemists and medicinal chemists who wish to be kept informed and up-to-date with the latest and most important developments about new bioactive compounds of natural or synthetic origin, including recent patents.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content